On March 20, Cleveland Clinic and IBM formally unveiled IBM Quantum System One installed in the Lerner Research Institute located at Cleveland Clinic's Main Campus.
Set to become the first private sector onsite, IBM-managed quantum computer in the United States, the two organizations plan to use IBM Quantum System One to usher in a new era of accelerated discovery in healthcare and life sciences.
Leaders from Cleveland Clinic and IBM came together to celebrate the opening of the first quantum in healthcare. Guests had an opportunity to network with the scientific and computational communities, learned more on how to get involved within the Discovery Accelerator and asked questions directly to Cleveland Clinic and IBM’s Discovery Accelerator leadership team.
Announced in 2021, the Cleveland Clinic-IBM Discovery Accelerator is a joint center that leverages Cleveland Clinic’s medical expertise with the technology expertise of IBM, including its leadership in quantum computing.
The Discovery Accelerator at Cleveland Clinic draws upon a variety of IBM’s latest advancements in high performance computing, including:
Generative Toolkit for Scientific Discovery and other generative modelling capabilities that leverage AI to infer knowledge gaps and generate hypotheses, and ultimately aim to speed up the research process in therapeutics and biomarkers discovery;
RXN, a cloud-based platform that combines AI models and the ability to directly control robotic labs to enable end-to-end design and synthesis of new chemical compounds;
Deep Search, a next-generation AI tool for generating insight from large amounts of structured and unstructured technical literature; and
High-Performance Hybrid Cloud Computing technologies that enable researchers to “burst” their workloads into the cloud and access the resources they need at scale.
The Discovery Accelerator also serves as the technology foundation for Cleveland Clinic’s Global Center for Pathogen Research & Human Health, part of the Cleveland Innovation District. The center, supported by a $500 million investment from the State of Ohio, Jobs Ohio and Cleveland Clinic, brings together a team focused on studying, preparing and protecting against emerging pathogens and virus-related diseases. Through Discovery Accelerator, researchers are leveraging advanced computational technology to expedite critical research into treatments and vaccines.
Together, the teams have already begun several collaborative projects that benefit from the new computational power. The Discovery Accelerator projects include a research study developing a quantum computing method to screen and optimize drugs targeted to specific proteins; improving a prediction model for cardiovascular risk following non-cardiac surgery; and using artificial intelligence to search genome sequencing findings and large drug-target databases to find effective, existing drugs that could help patients with Alzheimer’s and other diseases.
A significant part of the collaboration is a focus on educating the workforce of the future and creating jobs to grow the economy. An innovative educational curriculum has been designed for participants from high school to professional level, offering training and certification programs in data science, machine learning and quantum computing to build the skilled workforce needed for cutting-edge computational research of the future.
Tom Mihaljevic, MD, is Chief Executive Officer and President of Cleveland Clinic, leading an $8 billion healthcare system that includes a main campus in Cleveland, Ohio, 11 regional hospitals, 18 family health centers, and facilities in Florida, Nevada, Toronto, Abu Dhabi, and London. Dr. Mihaljevic previously served as CEO of Cleveland Clinic Abu Dhabi (CCAD), where he oversaw the opening of the 365-bed hospital and clinic, with 3,000 caregivers, in 2015. Under his leadership, CCAD expanded its treatment capabilities, built relationships in the private and public sectors, and established its growing reputation for clinical excellence, research, and education. From 2010 to 2015, Dr. Mihaljevic was chief of staff and chairman of the Heart, Vascular & Thoracic Institute at CCAD. He led a recruitment effort that drew 5,500 applications for 175 physician posts, and went on to launch the most advanced cardiovascular program in the Middle East. Dr. Mihaljevic joined Cleveland Clinic in 2004 as a surgeon in the Department of Thoracic and Cardiovascular Surgery. He has performed almost 3,000 operations over the course of his career, specializing in minimally invasive and robotically assisted procedures, valve replacement and repair, image-guided surgery, heart failure and cardiac transplantation.
Welcome and Panel Introduction
Featuring:
Tom Mihaljevic, MD | CEO & President, Cleveland Clinic
Brian Donley, MD | CEO, Cleveland Clinic London
Jamanda Haddock, MA, MRCP, FRCR | Associate Chief of Staff and Chair of Hospital Services, Cleveland Clinic London
Moderated by: Angela Rossi, Chief Human Resources Officer
Panel Discussion and Audience Q&A
Chair of the Board Remarks | Beth Mooney
Ribbon Cutting Ceremony
